Yuko M Komesu1, Holly E Richter2, Darrell L Dinwiddie3, Nazema Y Siddiqui4, Vivian W Sung5, Emily S Lukacz6, Beri Ridgeway7, Lily A Arya8, Halina M Zyczynski9, Rebecca G Rogers10, Marie Gantz11. 1. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology MSC10-5580, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131-0001, USA. ykomesu@salud.unm.edu. 2. Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA. 3. Clinical Translational Sciences Center and Department of Pediatrics, University of New Mexico of New Mexico Health Sciences Center, Albuquerque, NM, USA. 4. Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA. 5. Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, Alpert Medical School of Brown University, Providence, RI, USA. 6. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Reproductive Medicine, UC San Diego Health System, San Diego, CA, USA. 7. Center for Urogynecology and Reconstructive Pelvic Surgery, Obstetrics and Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA. 8. Division of Urogynecology and Reconstructive Pelvic Surgery, Hospital of University of Pennsylvania, Philadelphia, PA, USA. 9. Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 10. Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology MSC10-5580, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131-0001, USA. 11. Social, Statistical and Environmental Sciences, RTI International, Research Triangle Park, Durham, NC, USA.
Abstract
INTRODUCTION AND HYPOTHESIS: We describe the rationale and methods of a study designed to compare vaginal and urinary microbiomes in women with mixed urinary incontinence (MUI) and similarly aged, asymptomatic controls. METHODS: This paper delineates the methodology of a supplementary microbiome study nested in an ongoing randomized controlled trial comparing a standardized perioperative behavioral/pelvic floor exercise intervention plus midurethral sling versus midurethral sling alone for MUI. Women in the parent study had at least "moderate bother" from urgency and stress urinary incontinence symptoms (SUI) on validated questionnaire and confirmed MUI on bladder diary. Controls had no incontinence symptoms. All participants underwent vaginal and urine collection for DNA analysis and conventional urine culture. Standardized protocols were designed, and a central lab received samples for subsequent polymerase chain reaction (PCR) amplification and sequencing of the bacterial16S ribosomal RNA (rRNA) gene. The composition of bacterial communities will be determined by dual amplicon sequencing of variable regions 1-3 and 4-6 from vaginal and urine specimens to compare the microbiome of patients with controls. Sample-size estimates determined that 126 MUI and 84 control participants were sufficient to detect a 20 % difference in predominant urinary genera, with 80 % power and 0.05 significance level. RESULTS: Specimen collection commenced January 2015 and finished April 2016. DNA was extracted and stored for subsequent evaluation. CONCLUSIONS: Methods papers sharing information regarding development of genitourinary microbiome studies, particularly with control populations, are few. We describe the rigorous methodology developed for a novel urogenital microbiome study in women with MUI.
RCT Entities:
INTRODUCTION AND HYPOTHESIS: We describe the rationale and methods of a study designed to compare vaginal and urinary microbiomes in women with mixed urinary incontinence (MUI) and similarly aged, asymptomatic controls. METHODS: This paper delineates the methodology of a supplementary microbiome study nested in an ongoing randomized controlled trial comparing a standardized perioperative behavioral/pelvic floor exercise intervention plus midurethral sling versus midurethral sling alone for MUI. Women in the parent study had at least "moderate bother" from urgency and stress urinary incontinence symptoms (SUI) on validated questionnaire and confirmed MUI on bladder diary. Controls had no incontinence symptoms. All participants underwent vaginal and urine collection for DNA analysis and conventional urine culture. Standardized protocols were designed, and a central lab received samples for subsequent polymerase chain reaction (PCR) amplification and sequencing of the bacterial16S ribosomal RNA (rRNA) gene. The composition of bacterial communities will be determined by dual amplicon sequencing of variable regions 1-3 and 4-6 from vaginal and urine specimens to compare the microbiome of patients with controls. Sample-size estimates determined that 126 MUI and 84 control participants were sufficient to detect a 20 % difference in predominant urinary genera, with 80 % power and 0.05 significance level. RESULTS: Specimen collection commenced January 2015 and finished April 2016. DNA was extracted and stored for subsequent evaluation. CONCLUSIONS: Methods papers sharing information regarding development of genitourinary microbiome studies, particularly with control populations, are few. We describe the rigorous methodology developed for a novel urogenital microbiome study in women with MUI.
Authors: Alan J Wolfe; Evelyn Toh; Noriko Shibata; Ruichen Rong; Kimberly Kenton; MaryPat Fitzgerald; Elizabeth R Mueller; Paul Schreckenberger; Qunfeng Dong; David E Nelson; Linda Brubaker Journal: J Clin Microbiol Date: 2012-01-25 Impact factor: 5.948
Authors: Peter J Turnbaugh; Ruth E Ley; Micah Hamady; Claire M Fraser-Liggett; Rob Knight; Jeffrey I Gordon Journal: Nature Date: 2007-10-18 Impact factor: 49.962
Authors: Evann E Hilt; Kathleen McKinley; Meghan M Pearce; Amy B Rosenfeld; Michael J Zilliox; Elizabeth R Mueller; Linda Brubaker; Xiaowu Gai; Alan J Wolfe; Paul C Schreckenberger Journal: J Clin Microbiol Date: 2013-12-26 Impact factor: 5.948
Authors: Pawel Gajer; Rebecca M Brotman; Guoyun Bai; Joyce Sakamoto; Ursel M E Schütte; Xue Zhong; Sara S K Koenig; Li Fu; Zhanshan Sam Ma; Xia Zhou; Zaid Abdo; Larry J Forney; Jacques Ravel Journal: Sci Transl Med Date: 2012-05-02 Impact factor: 17.956
Authors: Linda Brubaker; Charles W Nager; Holly E Richter; Anthony Visco; Ingrid Nygaard; Matthew D Barber; Joseph Schaffer; Susan Meikle; Dennis Wallace; Noriko Shibata; Alan J Wolfe Journal: Int Urogynecol J Date: 2014-02-11 Impact factor: 2.894
Authors: Huma Siddiqui; Alexander J Nederbragt; Karin Lagesen; Stig L Jeansson; Kjetill S Jakobsen Journal: BMC Microbiol Date: 2011-11-02 Impact factor: 3.605
Authors: Nazema Y Siddiqui; Li Ma; Linda Brubaker; Jialiang Mao; Carter Hoffman; Erin M Dahl; Zhuoqun Wang; Lisa Karstens Journal: Front Cell Infect Microbiol Date: 2022-07-08 Impact factor: 6.073
Authors: Seth D Merkley; Samuel M Goodfellow; Yan Guo; Zoe E R Wilton; Janie R Byrum; Kurt C Schwalm; Darrell L Dinwiddie; Rama R Gullapalli; Vojo Deretic; Anthony Jimenez Hernandez; Steven B Bradfute; Julie G In; Eliseo F Castillo Journal: J Crohns Colitis Date: 2022-02-23 Impact factor: 10.020
Authors: Holly E Richter; Megan U Carnes; Yuko M Komesu; Emily S Lukacz; Lily Arya; Megan Bradley; Rebecca G Rogers; Vivian W Sung; Nazema Y Siddiqui; Benjamin Carper; Donna Mazloomdoost; Darryl Dinwiddie; Marie G Gantz Journal: Am J Obstet Gynecol Date: 2021-07-21 Impact factor: 10.693
Authors: Yuko M Komesu; Holly E Richter; Benjamin Carper; Darrell L Dinwiddie; Emily S Lukacz; Nazema Y Siddiqui; Vivian W Sung; Halina M Zyczynski; Beri Ridgeway; Rebecca G Rogers; Lily A Arya; Donna Mazloomdoost; Marie G Gantz Journal: Int Urogynecol J Date: 2018-06-16 Impact factor: 1.932
Authors: Carrie E Jung; Jessica Chopyk; Ji Hyun Shin; Emily S Lukacz; Linda Brubaker; Leila K Schwanemann; Rob Knight; Alan J Wolfe; David T Pride Journal: Sci Rep Date: 2019-09-16 Impact factor: 4.379